Neopharma Receives Approval From UAE Ministry of Health to Manufacture H1N1 Medicine
His Excellency Abdulla Humaid Al Mazroei, Vice-Chairman, Neopharma, and Dr.B.R. Shetty, Managing Director and CEO, thanked the UAE Ministry of Health on behalf of the Board of Directors of the company.
Dr. Shetty said: "The endorsement for the antiviral drug to be manufactured by Neopharma reflects the strong support of the Ministry of Health for the vision of the UAE leadership to create a self-sustaining community. As a leading manufacturer of life-saving drugs, we believe it is our responsibility to play a vital role in helping the community at this critical juncture.
Neopharma's Oseltamivir BR Flu is the outcome of a joint venture with Hetero Drugs Ltd and is the first in a series of major life-saving drugs the company plans to produce over the next few years.
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.